Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6218-6226

  Molloy, Michael J ^a   Zhang, Weijun ^a   Usherwood, Edward J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GAMMAHERPESVIRINAE; HERPES VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-10; SPLEEN;

EID: 79958065325     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003812     Document Type: Article

References (58)

1. Verucchi, G., L. Calza, R. Manfredi, and F. Chiodo. 2004. Human immuno-deficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection 32: 33-46. (Pubitemid 38210511)
2. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78: 5535-5545.
3. Brooks, D. G., L. Teyton, M. B. Oldstone, and D. B. McGavern. 2005. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 79: 10514-10527.
4. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6: 873-879.
5. Virgin, H. W., E. J. Wherry, and R. Ahmed. 2009. Redefining chronic viral infection. Cell 138: 30-50.
6. Fuse, S., M. J. Molloy, and E. J. Usherwood. 2008. Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions. Crit. Rev. Immunol. 28: 159-183.
7. Blackburn, S. D., H. Shin, W. N. Haining, T. Zou, C. J. Workman, A. Polley, M. R. Betts, G. J. Freeman, D. A. Vignali, and E. J. Wherry. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
8. Jin, H. T., A. C. Anderson, W. G. Tan, E. E. West, S. J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, and R. Ahmed. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. U S A. 107: 14733-14738.
9. Ha, S. J., E. E. West, K. Araki, K. A. Smith, and R. Ahmed. 2008. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunol. Rev. 223: 317-333.
10. Dias, P., F. Giannoni, L. N. Lee, D. Han, S. Yoon, H. Yagita, M. Azuma, and S. R. Sarawar. 2010. CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions. J. Virol. 84: 8241-8249.
11. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
12. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
13. Miyazoe, S., K. Hamasaki, K. Nakata, Y. Kajiya, K. Kitajima, K. Nakao, M. Daikoku, H. Yatsuhashi, M. Koga, M. Yano, and K. Eguchi. 2002. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 97: 2086-2092.
14. Persico, M., M. Capasso, E. Persico, M. Masarone, A. Renzo, D. Spano, S. Bruno, and A. Iolascon. 2006. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J. Hepatol. 45: 779-785. (Pubitemid 44646685)
15. Knapp, S., B. J. Hennig, A. J. Frodsham, L. Zhang, S. Hellier, M. Wright, R. Goldin, A. V. Hill, H. C. Thomas, and M. R. Thursz. 2003. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55: 362-369.
16. Shin, H. D., C. Winkler, J. C. Stephens, J. Bream, H. Young, J. J. Goedert, T. R. O'Brien, D. Vlahov, S. Buchbinder, J. Giorgi, et al. 2000. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl. Acad. Sci. USA 97: 14467-14472.
17. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
18. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472.
19. Maris, C. H., C. P. Chappell, and J. Jacob. 2007. Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunol. 8: 8.
20. Humphreys, I. R., C. de Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware. 2007. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J. Exp. Med. 204: 1217-1225.
21. Rigopoulou, E. I., W. G. Abbott, P. Haigh, and N. V. Naoumov. 2005. Blocking of interleukin-10 receptor - a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 117: 57-64.
22. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix, A. Sher, R. L. Coffman, and G. M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93: 768-775.
23. Biswas, P. S., V. Pedicord, A. Ploss, E. Menet, I. Leiner, and E. G. Pamer. 2007. Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J. Immunol. 179: 4520-4528.
24. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15: 405-431.
25. Grogg, K. L., R. F. Miller, and A. Dogan. 2007. HIV infection and lymphoma. J. Clin. Pathol. 60: 1365-1372.
26. El-Far, M., R. Halwani, E. Said, L. Trautmann, M. Doroudchi, L. Janbazian, S. Fonseca, J. van Grevenynghe, B. Yassine-Diab, R. P. Sékaly, and E. K. Haddad. 2008. T-cell exhaustion in HIV infection. Curr. HIV/AIDS Rep. 5: 13-19.
27. Bevan, M. J. 2004. Helping the CD8(+) T-cell response. Nat. Rev. Immunol. 4: 595-602.
28. -/-) mice. J. Gen. Virol. 84: 337-341.
29. Cardin, R. D., J. W. Brooks, S. R. Sarawar, and P. C. Doherty. 1996. Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184: 863-871.
30. Stevenson, P. G., G. T. Belz, J. D. Altman, and P. C. Doherty. 1998. Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95: 15565-15570.
31. Belz, G. T., P. G. Stevenson, M. R. Castrucci, J. D. Altman, and P. C. Doherty. 2000. Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice. Proc. Natl. Acad. Sci. USA 97: 2725-2730.
32. Nicholas, J. 2005. Human gammaherpesvirus cytokines and chemokine receptors. J. Interferon Cytokine Res. 25: 373-383. (Pubitemid 41026259)
33. Slobedman, B., P. A. Barry, J. V. Spencer, S. Avdic, and A. Abendroth. 2009. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J. Virol. 83: 9618-9629.
34. Siegel, A. M., J. H. Herskowitz, and S. H. Speck. 2008. The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog. 4: e1000039.
35. Peacock, J. W., and K. L. Bost. 2001. Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology 104: 109-117.
36. Flaño, E., B. Kayhan, D. L. Woodland, and M. A. Blackman. 2005. Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation. J. Immunol. 175: 3225-3234.
37. Sunil-Chandra, N. P., S. Efstathiou, J. Arno, and A. A. Nash. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73: 2347-2356.
38. Usherwood, E. J., K. A. Ward, M. A. Blackman, J. P. Stewart, and D. L. Woodland. 2001. Latent antigen vaccination in a model gammaherpesvirus infection. J. Virol. 75: 8283-8288.
39. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499-4506.
40. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
41. Serafini, P., C. De Santo, I. Marigo, S. Cingarlini, L. Dolcetti, G. Gallina, P. Zanovello, and V. Bronte. 2004. Derangement of immune responses by myeloid suppressor cells. Cancer Immunol. Immunother. 53: 64-72.
42. Maynard, C. L., L. E. Harrington, K. M. Janowski, J. R. Oliver, C. L. Zindl, A. Y. Rudensky, and C. T. Weaver. 2007. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp32 precursor cells in the absence of interleukin 10. Nat. Immunol. 8: 931-941.
43. Dinesh, R. K., B. J. Skaggs, A. La Cava, B. H. Hahn, and R. P. Singh. 2010. CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun. Rev. 9: 560-568.
44. Dai, H., N. Wan, S. Zhang, Y. Moore, F. Wan, and Z. Dai. 2010. Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. J. Immunol. 185: 803-807.
45. Blackburn, S. D., and E. J. Wherry. 2007. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 15: 143-146.
46. Filippi, C. M., and M. G. von Herrath. 2008. IL-10 and the resolution of infections. J. Pathol. 214: 224-230. (Pubitemid 351160159)
47. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
48. Smith, C. M., N. S. Wilson, J. Waithman, J. A. Villadangos, F. R. Carbone, W. R. Heath, and G. T. Belz. 2004. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5: 1143-1148.
49. Janssen, E. M., N. M. Droin, E. E. Lemmens, M. J. Pinkoski, S. J. Bensinger, B. D. Ehst, T. S. Griffith, D. R. Green, and S. P. Schoenberger. 2005. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434: 88-93.
50. Cosmi, L., F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi, V. Santarlasci, R. Manetti, V. Vanini, P. Romagnani, et al. 2003. Human CD8+CD25 + thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102: 4107-4114. (Pubitemid 37486995)
51. Billerbeck, E., H. E. Blum, and R. Thimme. 2007. Parallel expansion of human virus-specific FoxP3- effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J. Immunol. 179: 1039-1048.
52. Accapezzato, D., V. Francavilla, M. Paroli, M. Casciaro, L. V. Chircu, A. Cividini, S. Abrignani, M. U. Mondelli, and V. Barnaba. 2004. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113: 963-972.
53. Alatrakchi, N., C. S. Graham, H. J. van der Vliet, K. E. Sherman, M. A. Exley, and M. J. Koziel. 2007. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J. Virol. 81: 5882-5892.
54. Elrefaei, M., C. A. Baker, N. G. Jones, D. R. Bangsberg, and H. Cao. 2008. Presence of suppressor HIV-specific CD8+ T cells is associated with increased PD-1 expression on effector CD8+ T cells. J. Immunol. 180: 7757-7763.
55. Elrefaei, M., B. Barugahare, F. Ssali, P. Mugyenyi, and H. Cao. 2006. HIV-specific IL-10-positive CD8+ T cells are increased in advanced disease and are associated with decreased HIV-specific cytolysis. J. Immunol. 176: 1274-1280. (Pubitemid 43099733)
56. Elrefaei, M., F. L. Ventura, C. A. Baker, R. Clark, D. R. Bangsberg, and H. Cao. 2007. HIV-specific IL-10-positive CD8+ T cells suppress cytolysis and IL-2 production by CD8+ T cells. J. Immunol. 178: 3265-3271. (Pubitemid 46333210)
57. Nordström, I., M. Nurkkala, L. V. Collins, and K. Eriksson. 2005. CD8+ T-cells suppress antigen-specific and allogeneic CD4+ T-cell responses to herpes simplex virus type 2-infected human dendritic cells. Viral Immunol. 18: 616-626. (Pubitemid 43045685)
58. Popescu, I., C. Macedo, K. Abu-Elmagd, R. Shapiro, Y. Hua, A. W. Thomson, A. E. Morelli, W. J. Storkus, and D. Metes. 2007. EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cells. Am. J. Transplant. 7: 1215-1223.